The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...

Russia’s unjustified and unprovoked invasion of Ukraine and the weaponisation of energy have made diversification of energy supplies a necessity for EU countries. Diversification is a lengthy and ...

the European Medicines Agency (EMA), endorsed its antibody-drug conjugate Dato-DXd marketed with AstraZeneca (NASDAQ:AZN) as a late-line option for certain cases of breast cancer. Issuing a so-cal ...

European Union regulators will review new information ... providing a response after a meeting next month. The drug, Leqembi, can slow the progression of Alzheimer’s, the mind-robbing disease ...

Several medicines are poised ... an accelerated assessment under the EMA's PRIority MEdicines program. The company expects to launch the product in key European markets in the first half of ...

Investing.com - European stock markets edged higher Friday ... citing strong demand for established heart failure drug Entresto and multiple sclerosis drug Kesimpta. Salvatore Ferragamo (BIT ...

The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in the U.S. and Japan. Datroway is used to treat patients with a type of ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name ...

Several drug classes are commonly used to treat MDD, including antidepressants, antipsychotics, anti-anxiety medications, and other types of mood-stabilizing drugs. This variety of classes can help ...

Prescription drugs can be administered in various ways. This includes oral (by mouth), enteral (into the gastrointestinal tract), mucosal (through a mucus membrane), and percutaneous (through the skin ...

Novartis has said it is “disappointed” that the EMA’s Human Medicines Committee has recommended revoking the conditional EU approval for sickle cell disease (SCD) therapy Adakveo ...